GlassScriptPhysician profile
Breanne M Phillips
NPI 1144418054
$1,069.98
in general payments reported to CMS, 2019-2025
22 companies · $877 in 2025
The $877 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.20 · 2023: $35.96 · 2024: $61.72 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.89 | 2025 | |
| Novo Nordisk INC | $147.94 | 2025 | Wegovy, Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $135.47 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $111.05 | 2022-2025 | |
| Axsome Therapeutics, INC. | $59.49 | 2025 | Symbravo, Auvelity |
| Janssen Pharmaceuticals, INC | $40.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $33.32 | 2022 | |
| Astellas Pharma US INC | $32.43 | 2025 | Veozah |
| Regeneron Healthcare Solutions, INC. | $30.22 | 2025 | Dupixent |
| Lilly USA, LLC | $29.14 | 2025 | Zepbound, Mounjaro |
| Radius Health, INC. | $28.78 | 2025 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $23.47 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $21.61 | 2023 | |
| Eisai INC. | $21.51 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.29 | 2025 | Jardiance |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $20.07 | 2025 | Voquezna |
| Scpharmaceuticals INC. | $19.26 | 2025 | |
| Glaxosmithkline, LLC. | $18.81 | 2025 | Arexvy |
| Alexion Pharmaceuticals, INC. | $18.52 | 2025 | Ultomiris |
| Actelion Pharmaceuticals US, INC. | $15.83 | 2025 | Uptravi, Opsumit |
| Exact Sciences Corporation | $15.34 | 2025 | The Cologuard Plus Collection Kit |
| Tactile Systems Technology INC | $14.35 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breanne Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.